Cours RLS Global AB (publ) Nasdaq Stockholm
Actions
SE0005190725
Produits pharmaceutiques
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Roland Frösing
CEO | Chief Executive Officer | 64 | 01/01/21 |
Director of Finance/CFO | 64 | 22/08/23 | |
Magnus Nolmark
COO | Chief Operating Officer | 59 | 01/01/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 71 | 01/08/12 | |
Director/Board Member | 63 | 01/08/17 | |
Anders Edvell
BRD | Director/Board Member | 55 | 01/01/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83 % | 661 Md | |
+27,00 % | 566 Md | |
-6,76 % | 352 Md | |
+20,34 % | 332 Md | |
+3,00 % | 283 Md | |
+13,09 % | 231 Md | |
+5,46 % | 200 Md | |
-9,61 % | 195 Md | |
-6,26 % | 145 Md |